- Conditions
- Hyperemesis Gravidarum, Nausea Gravidarum, Vomiting of Pregnancy
- Interventions
- Capsaicin Topical Cream, Metoclopramide, Ondansetron, Lactated Ringers, Intravenous
- Drug
- Lead sponsor
- Women and Infants Hospital of Rhode Island
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Morning Sickness
- Interventions
- Bonjesta, Placebo
- Drug
- Lead sponsor
- Duchesnay Inc.
- Industry
- Eligibility
- 12 Years to 17 Years · Female only
- Enrollment
- 274 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2027
- U.S. locations
- 10
- States / cities
- Burbank, California • Hialeah, Florida • Miami, Florida + 7 more
- Conditions
- Hyperemesis Gravidarum
- Interventions
- Metformin Extended Release Oral Tablet
- Drug
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 224 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Los Angeles, California
- Conditions
- Pregnancy, Pregnancy Complications, Morning Sickness, Diabetes, Gestational, Placenta Diseases, Birth Weight
- Interventions
- No Interventions
- Other
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 2,359 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2023
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Pregnancy, Severe Nausea and Vomiting, Hyperemesis Gravidarum
- Interventions
- Mirtazapine
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 49 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Nausea and Vomiting of Pregnancy
- Interventions
- doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg, Placebo
- Drug
- Lead sponsor
- Duchesnay Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 7
- States / cities
- Washington D.C., District of Columbia • Bethesda, Maryland • Pittsburgh, Pennsylvania + 3 more
- Conditions
- Hyperemesis Gravidarum
- Interventions
- Gabapentin, Metoclopramide
- Drug
- Lead sponsor
- State University of New York at Buffalo
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 2
- States / cities
- Buffalo, New York • Rochester, New York
- Conditions
- Morning Sickness, Pregnancy Early
- Interventions
- Citrus-Based Aromatherapy, Mint-Based Aromatherapy, Spice-Scented Aromatherapy, Control
- Other
- Lead sponsor
- Nutraceuticals Research Institute
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 74 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Franklin, Tennessee
- Conditions
- Morning Sickness
- Interventions
- Diclegis, Placebo (Sugar Pill)
- Drug
- Lead sponsor
- Duchesnay Inc.
- Industry
- Eligibility
- 12 Years to 17 Years · Female only
- Enrollment
- 131 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2017
- U.S. locations
- 8
- States / cities
- Tucson, Arizona • Los Angeles, California • Norwalk, California + 5 more